Abstract Coronavirus disease 2019 (COVID-19) predisposes patients to thrombotic and
thromboembolic events, owing to excessive inflammation, endothelial cell activation and …

Abstract Coronavirus disease 2019 (COVID-19) induced by SARS-Cov-2 can be related to
coagulopathy. Also, the infection-induced inflammatory changes are found in patients with …

A high incidence of thrombosis in hospitalised patients with COVID-19 was identified early
during the pandemic. Accurately quantifying thrombotic risk may assist prognosis and guide …

Background The novel coronavirus SARS-CoV-2, responsible for the 2019–2020 global
(COVID-19) pandemic, is a respiratory virus associated with the development of …

The novel Corona virus infection (Covid-19) first identified in China in December 2019 has
rapidly progressed in pandemic leading to significant mortality and unprecedented …

Patients with coronavirus disease 2019 (COVID-19) have elevated D-dimer levels. Early
reports describe high venous thromboembolism (VTE) and disseminated intravascular …

Coronavirus-2019 (COVID-19) predisposes patients to arterial and venous thrombosis
commonly complicating the clinical course of hospitalized patients and attributed to the …

Background Infection by the 2019 novel coronavirus (COVID-19) has been reportedly
associated with a high risk of thrombotic complications. So far information is scarce and …

Abstract Background and Aims Patients with severe coronavirus disease 2019 (COVID‐19)
are at significant risk of thrombotic complications. However, their prothrombotic state is …

The novel coronavirus disease (COVID-19) is associated with a high incidence of
coagulopathy and venous thromboembolism that may contribute to the worsening of the …